ArticleCells2025

Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer.

Hajime Matsuida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.